Limits...
Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery.

Nath B, Nath LK - J Pharm (Cairo) (2012)

Bottom Line: Chitosan in the mixed film coat was found to be degraded by enzymatic action of the microflora in the colon.Release kinetic data revealed that the optimized MCDDS was fitted well into first-order model, and apparent lag time was found to be 6 hours, followed by Higuchi release kinetics.In vivo study in rabbits shows delayed T max, prolonged absorption time, decreased C max, and absorption rate constant (Ka), indicating a reduced systemic toxicity of the drug as compared to other dosage forms.

View Article: PubMed Central - PubMed

Affiliation: Department of Pharmaceutical Sciences, Girijananda Chowdhury Institute of Pharmaceutical Sciences (GIPS), Azara, Assam, Guwahati 781001, India ; Girijananda Chowdhury Institute of Pharmaceutical Sciences (GIPS) Affiliated to Gauhati University, Azara, Assam, Guwahati 781017, India.

ABSTRACT
The purpose of this study is to explore the possible applicability of Sterculia urens gum as a novel carrier for colonic delivery system of a sparingly soluble drug, azathioprine. The study involves designing a microflora triggered colon-targeted drug delivery system (MCDDS) which consists of a central polysaccharide core and is coated to different film thicknesses with blends of chitosan/Eudragit RLPO, and is overcoated with Eudragit L00 to provide acid and intestinal resistance. The microflora degradation property of gum was investigated in rat caecal medium. Drug release study in simulated colonic fluid revealed that swelling force of the gum could concurrently drive the drug out of the polysaccharide core due to the rupture of the chitosan/Eudargit coating in microflora-activated environment. Chitosan in the mixed film coat was found to be degraded by enzymatic action of the microflora in the colon. Release kinetic data revealed that the optimized MCDDS was fitted well into first-order model, and apparent lag time was found to be 6 hours, followed by Higuchi release kinetics. In vivo study in rabbits shows delayed T max, prolonged absorption time, decreased C max, and absorption rate constant (Ka), indicating a reduced systemic toxicity of the drug as compared to other dosage forms.

No MeSH data available.


Related in: MedlinePlus

Dissolution rate profile of optimized MCDDS under continuous dissolution rate test in different media (0–2 h in SGF at pH 1.2, 2–6 h in SIF at pH 6.8 and the rest of experiment in SCF at pH 7.4).
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4595939&req=5

fig6: Dissolution rate profile of optimized MCDDS under continuous dissolution rate test in different media (0–2 h in SGF at pH 1.2, 2–6 h in SIF at pH 6.8 and the rest of experiment in SCF at pH 7.4).

Mentions: Results of in vitro dissolution study showed that the over coating with 10% w/w of enteric coating material (eudragit L100, dissolves above pH 6.0) provided the desired acid and intestinal resistance of the optimized chitosan-eudragit RLPO coated tablet. Figure 6 shows the in vitro release profile of optimized MCDDS in sequential phosphate buffer medium at different pH releasing more than 90% of the drug within 24 h duration.


Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery.

Nath B, Nath LK - J Pharm (Cairo) (2012)

Dissolution rate profile of optimized MCDDS under continuous dissolution rate test in different media (0–2 h in SGF at pH 1.2, 2–6 h in SIF at pH 6.8 and the rest of experiment in SCF at pH 7.4).
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4595939&req=5

fig6: Dissolution rate profile of optimized MCDDS under continuous dissolution rate test in different media (0–2 h in SGF at pH 1.2, 2–6 h in SIF at pH 6.8 and the rest of experiment in SCF at pH 7.4).
Mentions: Results of in vitro dissolution study showed that the over coating with 10% w/w of enteric coating material (eudragit L100, dissolves above pH 6.0) provided the desired acid and intestinal resistance of the optimized chitosan-eudragit RLPO coated tablet. Figure 6 shows the in vitro release profile of optimized MCDDS in sequential phosphate buffer medium at different pH releasing more than 90% of the drug within 24 h duration.

Bottom Line: Chitosan in the mixed film coat was found to be degraded by enzymatic action of the microflora in the colon.Release kinetic data revealed that the optimized MCDDS was fitted well into first-order model, and apparent lag time was found to be 6 hours, followed by Higuchi release kinetics.In vivo study in rabbits shows delayed T max, prolonged absorption time, decreased C max, and absorption rate constant (Ka), indicating a reduced systemic toxicity of the drug as compared to other dosage forms.

View Article: PubMed Central - PubMed

Affiliation: Department of Pharmaceutical Sciences, Girijananda Chowdhury Institute of Pharmaceutical Sciences (GIPS), Azara, Assam, Guwahati 781001, India ; Girijananda Chowdhury Institute of Pharmaceutical Sciences (GIPS) Affiliated to Gauhati University, Azara, Assam, Guwahati 781017, India.

ABSTRACT
The purpose of this study is to explore the possible applicability of Sterculia urens gum as a novel carrier for colonic delivery system of a sparingly soluble drug, azathioprine. The study involves designing a microflora triggered colon-targeted drug delivery system (MCDDS) which consists of a central polysaccharide core and is coated to different film thicknesses with blends of chitosan/Eudragit RLPO, and is overcoated with Eudragit L00 to provide acid and intestinal resistance. The microflora degradation property of gum was investigated in rat caecal medium. Drug release study in simulated colonic fluid revealed that swelling force of the gum could concurrently drive the drug out of the polysaccharide core due to the rupture of the chitosan/Eudargit coating in microflora-activated environment. Chitosan in the mixed film coat was found to be degraded by enzymatic action of the microflora in the colon. Release kinetic data revealed that the optimized MCDDS was fitted well into first-order model, and apparent lag time was found to be 6 hours, followed by Higuchi release kinetics. In vivo study in rabbits shows delayed T max, prolonged absorption time, decreased C max, and absorption rate constant (Ka), indicating a reduced systemic toxicity of the drug as compared to other dosage forms.

No MeSH data available.


Related in: MedlinePlus